4'-(Bromomethyl)-[1,1'-biphenyl]-4-carbonitrile, 250mg

1-(3-Methoxy-4-nitrophenyl)piperidin-4-ol, 95.0%, 10g

2-AMINO-4-BROMO-3-METHYLPHENOL, 95.0%, 100mg

6-Methyl-3(2H)-pyridazinone>98.0%(GC)1g

6-Bromo-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine, 98%, 1g

Thalidomide-O-amido-PEG2-C2-NH2 (TFA), 1g

Tube à essai ROTILABO® à bord perlé, à paroi mince, 80 ml, 50 unité(s), 50 Pièce(s)

(1R)-1-[6-(trifluoromethyl)(3-pyridyl)]ethylamine, 97%, 100mg

(R)-2-amino-3-(4-chloro-2-fluorophenyl)propanoic acid, 98%, 1g

5-(tert-Butyloxycarbonyamino)methyl-3-(4-(trifluoromethyl)phenyl)-[1,2,4]oxadiazole, 95.0%, 5g

2-Amino-5-[2-(trifluoromethyl)phenyl]-1,3,4-thiadiazole, 98.0%, 250mg

Acétate de violet de crésyl, 25 g

4-Bromo-2-fluoro-6-nitrophenol, 98.0%, 500g